Bexarotene
287A
Phase 2 small_molecule completed
Quick answer
Bexarotene for Sarcoma, Kaposi is a Phase 2 program (small_molecule) at LIGAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LIGAND PHARMACEUTICALS INC
- Indication
- Sarcoma, Kaposi
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed